Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer
Clinical trial NCT04034589 · UNKNOWN
Trial details
- NCT number
- NCT04034589
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2021-07-06
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.